Trump Threatens 200% Tariff On Indian Pharma! Why India Isn't Worried? Generic Drugs | Kinjal

Описание: Why has Donald Trump announced up to 200% tariffs on imported generic medicines, why India is the biggest country affected, and what this means for India's pharmaceutical exports, the US healthcare system, and future India-US trade relations.
~~~~~~~~~~~~~~~~~~~~~~~~~~~
1. 💜 Iconic Pro Starting at just ₹74,999 | Flat 60% OFF
🚀 Enroll Now:
https://unacademy.com/goal/upsc-civil...
⏳ Early Bird Offer Ends on 24th July | Only 30 Seats per Educator

👉 Enrol Today & Strengthen Your UPSC Journey

2. Unacademy's New Initiative for UPSC Aspirants
Test Link : https://unacademy.com/scholarship/UCAN
Weekly Current Affairs Tests based on UCAN Topics
---------------------------------------------------------------------
Donald Trump has announced one of the biggest policy shifts for the global pharmaceutical industry by proposing tariffs of up to 200% on imported generic medicines. Since India is the world's largest supplier of affordable generic drugs and exports nearly $10 billion worth of pharmaceuticals to the United States, this decision could have massive implications for Indian pharmaceutical companies, global medicine prices, and India-US trade relations.

In this video, we explain why Trump wants pharmaceutical manufacturing to shift back to America, how the new tariff timeline will work, why India is likely to be the biggest country impacted, and whether Indian pharma companies can adapt by investing in manufacturing facilities in the United States. We also discuss the impact on Indian companies like Sun Pharma, Dr. Reddy's, Cipla, Lupin, Aurobindo Pharma, Zydus Lifesciences, and the broader implications for investors, exporters, UPSC aspirants, and current affairs learners.

We also examine how this policy fits into Trump's broader "America First" trade strategy, ongoing India-US trade negotiations, global supply chains, and the future of affordable medicines worldwide.

Watch till the end for a complete analysis covering economy, international relations, trade policy, pharmaceuticals, exports, tariffs, and UPSC Current Affairs 2026.

#Trump #DonaldTrump #TrumpTariffs #IndiaUSRelations #IndiaUSTrade #GenericDrugs #PharmaIndustry #IndianPharma #MedicineExports #USPharma #Tariffs #TradeWar #AmericaFirst #IndianEconomy #SunPharma #DrReddys #Cipla #Lupin #AurobindoPharma #Zydus #CurrentAffairs #UPSC #UPSC2027 #UPSC2028 #InternationalRelations #GlobalEconomy #TradePolicy #EconomicNews #PharmaceuticalIndustry #IndiaNews
~~~~~~~~~~~~~~~~
Telegram channel for Daily Updates: https://t.me/worldaffairsbyunacademy

Trump 200 percent tariff on generic drugs explained Trump tariff on Indian medicines why Trump imposed tariff on generic drugs India pharma exports to USA explained impact of Trump tariff on Indian pharmaceutical industry India US trade relations latest news Trump America First pharma policy explained generic medicines export from India to America India's pharmacy of the world explained India pharma export news 2026 Donald Trump latest tariff announcement India US trade deal latest update pharmaceutical exports from India latest news impact of US tariffs on Indian economy Trump trade war with India explained why US wants pharma manufacturing back impact on Sun Pharma Dr Reddys Cipla Lupin Aurobindo Zydus pharmaceutical sector latest news global pharmaceutical supply chain explained international trade current affairs UPSC economy current affairs India US economic relations UPSC current affairs July 2026 international relations current affairs generic drug imports into USA Trump Truth Social tariff announcement explained